Pfizer Inc (PFE)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$22.30
Buy
$22.32
$-0.26 (-1.15%)
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
Prices updated at 10 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Dr. Albert Bourla, D.V.M.,PhD
CEO
Dr. Albert Bourla, D.V.M.,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
81,000
Head office
66 Hudson Boulevard East
New York
United States
10001-2192
Key personnel
Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
---|---|---|---|---|---|
Mr. David M. Denton Chief Financial Officer and Executive Vice President | 1.35m | - | - | 8.12m | - |
Ms. Lidia L. Fonseca Executive Vice President, Chief Digital and Technology Officer | - | - | - | - | - |
Ms. Sally Susman Chief Corporate Affairs Officer and Executive Vice President | - | - | - | - | - |
Mr. Ronald E. Blaylock Independent Director | 0.16m | - | - | 0.36m | - |
Mr. Shantanu Narayen Lead Independent Director | 0.21m | - | - | 0.45m | - |
Ms. Suzanne Nora Johnson Independent Director | 0.19m | - | - | 0.41m | - |
Dr. Scott Gottlieb,M.D. Independent Director | 0.19m | - | - | 0.39m | - |
Mr. James Robert Quincey Independent Director | 0.16m | - | - | 0.38m | - |
Dr. Susan J. Hockfield, PhD Independent Director | 0.16m | - | - | 0.36m | - |
Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H. Independent Director | 0.16m | - | - | 0.36m | - |
Mr. Douglas M. Lankler Chief Legal Officer and Executive Vice President | - | - | - | - | - |
Mr. James C. Smith Independent Director | 0.19m | - | - | 0.39m | - |
Dr. Albert Bourla, D.V.M.,PhD Chairman of the Board and Chief Executive Officer | 1.80m | - | - | 24.65m | - |
Mr. Joseph J. Echevarria Independent Director | 0.19m | - | - | 0.39m | - |
Ms. Margaret M. Madden Senior Vice President, Corporate Secretary and Chief Governance Counsel | - | - | - | - | - |
Mr. Cyrus Taraporevala Independent Director | 0.08m | - | - | 0.27m | - |
Dr. Dan R. Littman, M.D.,PhD Independent Director | 0.16m | - | - | 0.38m | - |
Ms. Jennifer B. Damico Principal Accounting Officer, Senior Vice President and Controller | - | - | - | - | - |
Ms. Payal Sahni Chief People Experience Officer and Executive Vice President | - | - | - | - | - |
Mr. Aamir Malik Chief U.S. Commercial Officer and Executive Vice President | 1.34m | - | - | 8.29m | - |
Mr. Michael McDermott Executive Vice President, Chief Global Supply and Quality Officer | - | - | - | - | - |
Dr. Chris Boshoff, M.D.,PhD Chief Scientific Officer and President, Research and Development | 1.20m | - | - | 7.85m | - |
Mr. Alexandre de Germay Chief International Commercial Officer and Executive Vice President | - | - | - | - | - |
Dr. Andrew Baum, M.D. Executive Vice President, Chief Strategy and Innovation Officer | - | - | - | - | - |
Mr. Mortimer J. Buckley Independent Director | 0.03m | - | - | 0.15m | - |
Top 5 shareholders
Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
---|---|---|---|---|---|---|
Vanguard Group Inc | 518,535,151 | 0.23961 | 2285276 | 0.442669 | 30 Apr 2025 | 9.12 |
BlackRock Inc | 451,740,051 | 0.24251 | 15738757 | 3.609796 | 30 Apr 2025 | 7.95 |
State Street Corp | 290,484,350 | 0.30402 | 23750 | 0.008177 | 30 Apr 2025 | 5.11 |
Vanguard Investments Australia Ltd | 182,505,369 | 2.95967 | 155991 | - | 30 Apr 2025 | 3.21 |
Vanguard US Total Market Shares ETF | 179,454,847 | 0.29715 | 129299 | 0.072103 | 30 Apr 2025 | 3.16 |
Director dealings
Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
---|---|---|---|---|---|---|---|
31 Dec 2024 | - | Mr. Shantanu Narayen | 26.53 | 49,983 | 154,711 | - | - |
31 Dec 2024 | - | Mr. James Robert Quincey | 26.53 | 38,734 | 55,029 | - | - |
31 Dec 2024 | - | Mr. James C. Smith | 26.53 | 44,995 | 139,544 | - | - |
31 Dec 2024 | - | Mr. Rady A. Johnson | 26.53 | 186 | 9,379 | - | - |
31 Dec 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 26.53 | 531 | 690,585 | - | - |
31 Dec 2024 | - | Mr. Joseph J. Echevarria | 26.53 | 46,242 | 123,639 | - | - |
31 Dec 2024 | - | Mr. Cyrus Taraporevala | 26.53 | 37,487 | 9,084 | - | - |
13 Dec 2024 | - | Mr. Rady A. Johnson | 25.58 | 179 | 9,373 | - | - |
13 Dec 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 25.58 | 537 | 690,626 | - | - |
29 Nov 2024 | - | Mr. Rady A. Johnson | 26.21 | 183 | 9,363 | - | - |
29 Nov 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 26.21 | 524 | 690,388 | - | - |
15 Nov 2024 | - | Mr. Rady A. Johnson | 24.80 | 198 | 9,365 | - | - |
15 Nov 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 24.80 | 521 | 691,116 | - | - |
31 Oct 2024 | - | Mr. Rady A. Johnson | 28.30 | 198 | 9,197 | - | - |
31 Oct 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 28.30 | 538 | 679,129 | - | - |
30 Oct 2024 | - | Dr. Scott Gottlieb,M.D. | 28.24 | 28,240 | 10,000 | - | - |
15 Oct 2024 | - | Mr. Rady A. Johnson | 29.44 | 177 | 9,189 | - | - |
15 Oct 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 29.44 | 530 | 679,044 | - | - |
10 Oct 2024 | - | Mr. Rady A. Johnson | 29.34 | 851 | 9,183 | - | - |
10 Oct 2024 | - | Dr. Albert Bourla, D.V.M.,PhD | 29.34 | 2,024 | 679,059 | - | - |
Please note that past performance is not a reliable indicator of future returns.